Joel Greenblatt’s Sanofi SNY Stock Holding History

Joel Greenblatt’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-32,588	Closed	-$1.56M	–	1031
2017 Q2	$1.56M	Hold	32,588	–	–	0.02%	565
2017 Q1	$1.48M	Sell	32,588 -444	-1%	-$18.8K	0.02%	599
2016 Q4	$1.34M	Buy	33,032 +153	+0.5%	+$6.03K	0.02%	561
2016 Q3	$1.26M	Sell	32,879 -2,692	-8%	-$108K	0.02%	568
2016 Q2	$1.49M	Buy	35,571 +851	+2%	+$34.9K	0.02%	575
2016 Q1	$1.39M	Buy	+34,720	New	+$1.39M	0.02%	617

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Joel Greenblatt's SNY Position: Q3 2017 in Review

Joel Greenblatt sold out of Sanofi (SNY) in Q3 2017, closing a stake of 32,588 shares — an estimated $1.56M sold.

Joel Greenblatt first reported a position in SNY in Q1 2016 and held it in 6 quarters. The position peaked at $1.56M in Q2 2017. 485 funds tracked by Wall St. Rank hold SNY as of Q3 2017.

Joel Greenblatt reported no remaining Sanofi position as of Q3 2017 after selling out during the quarter.
Joel Greenblatt sold 32,588 Sanofi shares in Q3 2017, an estimated $1.56M.
Joel Greenblatt first reported a position in Sanofi in Q1 2016 and held it in 6 quarters.
Joel Greenblatt's Sanofi position peaked at $1.56M in Q2 2017.
485 funds tracked by Wall St. Rank held Sanofi as of Q3 2017.

Based on Gotham Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.